Who owns NOVOCURE LIMITED?

Tip: Access positions for across all investors

Analyze quarterly positions in Novocure with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Novocure stock

Who bought or sold NOVOCURE LIMITED this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Braidwell 211M $210M 50% Sep 2025
 View chart
Tenor Capital Management 116M $115M 19% Sep 2025
 View chart
Opti Capital Management 75M $75B 0% Sep 2025
 View chart
DeepCurrents Investment Group 70M $69M 0% Sep 2025
 View chart
Millennium Management 35M $35M -1% Sep 2025
 View chart
State Street Corporation 11M $11M 5% Sep 2025
 View chart
Piper Jaffray & Co. 11M $11B 100% Sep 2025
 View chart
Kim 8.2M $8.1M 100% Sep 2025
 View chart
Radcliffe Capital Management 5.5M $5.4M 100% Sep 2025
 View chart
Oaktree Capital Management 4.3M $4.3M 82% Sep 2025
 View chart
Kohlberg Kravis Roberts & Co 3.5M $3.4M -10% Sep 2025
 View chart
Russell Investments 3.4M $3.4M 82% Sep 2025
 View chart
Verition Fund Management 3.0M $3.0M 0% Sep 2025
 View chart
D. E. Shaw & Co 2.5M $2.5M 0% Sep 2025
 View chart
Palisade Capital Management 1.2M $1.2M 26% Sep 2025
 View chart
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 1.0M $986k 0% Sep 2025
 View chart
Zazove Associates 158k $157k 0% Sep 2025
 View chart
Commonwealth of Pennsylvania 40k $40k 100% Sep 2025
 View chart
Advisory Services Network 16k $16k 0% Sep 2025
 View chart

Who sold out of Novocure?

Fund or Company Name Date Sold Shares Held Valued At
Ing Investment Management Jun 2025 65M $63M
Linden Advisors Jun 2025 35M $34M
Bnp Paribas Arbitrage, Snc Jun 2025 11M $11M
Wells Fargo & Company Jun 2025 224k $219k
Barclays Jun 2025 107k $104k
Leucadia National Corporation Jun 2025 20k $20k